Welcome to our dedicated page for ALEXANDRIA REAL ESTATE EQUITIES SEC filings (Ticker: ARE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ALEXANDRIA REAL ESTATE EQUITIES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ALEXANDRIA REAL ESTATE EQUITIES's regulatory disclosures and financial reporting.
Alexandria Real Estate Equities, Inc. is a Maryland-based S&P 500 life science REIT focused on Class A/A+ laboratory properties in major innovation clusters such as Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, New York City, and Texas.
As of December 31, 2025, the company reports a $20.75 billion total market capitalization and a North American asset base of 39.4 million RSF of operating and under‑construction space across 340 properties, including 3.5 million RSF of Class A/A+ projects under construction. Operating properties in North America were 90.9% occupied, versus a 10‑year average occupancy of 95%, and investment‑grade or publicly traded large‑cap tenants represented 53% of annual rental revenue in effect.
The company emphasizes its Megacampus™ ecosystem strategy, disciplined development and redevelopment, diversified funding sources, and a balance sheet focused on liquidity, low to modest leverage, and staggered debt maturities. Human capital is another focus: Alexandria had 514 employees as of December 31, 2025, reports voluntary and total turnover below REIT industry averages, and offers fully company‑paid health benefits and development programs to attract and retain experienced real estate and life science professionals.
ALEXANDRIA REAL ESTATE EQUITIES, INC. director Claire Aldridge reported acquiring 3,493 shares of common stock on January 15, 2026, at a reported price of $0 per share. This appears as an acquisition of non-derivative equity, increasing her directly held position.
Following this transaction, Aldridge is shown as beneficially owning 4,493 shares of Alexandria Real Estate common stock in direct ownership. The filing reflects a single reported transaction and does not list any derivative securities activity.
Alexandria Real Estate Equities, Inc. reported initial insider holdings for a regional executive. Regional Market Director Mitchell Joshua J. filed an initial ownership statement showing beneficial ownership of 13,091 shares of Alexandria Real Estate Equities, Inc. common stock as of 01/09/2026. The filing classifies the holdings as directly owned, and no stock options or other derivative securities are listed. This Form 3 serves as a baseline disclosure of the officer’s equity position with the company.
Alexandria Real Estate Equities, Inc. director reports share acquisition. Director Maria C. Freire reported acquiring 3,493 shares of Alexandria Real Estate Equities, Inc. common stock on January 15, 2026 at a reported price of $0 per share, as shown by transaction code "A". After this transaction, she directly owned a total of 10,946 common shares of the company.
Alexandria Real Estate Equities, Inc. director reports stock acquisition
Director Michael A. Woronoff reported acquiring 3,772 shares of Alexandria Real Estate Equities, Inc. common stock on 01/15/2026, at a reported price of $0 per share. Following this transaction, he directly holds 25,964 common shares. The filing also reports an additional 1,400 common shares held indirectly in a trust.
Alexandria Real Estate Equities, Inc. director Steve Hash reported a new stock award. On January 15, 2026, he acquired 3,732 shares of the company’s common stock in a transaction coded “A,” at a reported price of $0 per share, indicating a no-cash equity grant. Following this award, he beneficially owns 30,314 common shares, held directly.
Alexandria Real Estate Equities, Inc. director James P. Cain reported acquiring additional company stock. On January 15, 2026, he acquired 3,583 shares of common stock at a reported price of $0 per share, which typically reflects a grant or award rather than an open-market purchase. Following this transaction, he beneficially owns 13,138 common shares directly.
Alexandria Real Estate Equities, Inc. director reports share acquisition
Director Sheila K. McGrath reported acquiring 3,556 shares of Alexandria Real Estate Equities, Inc. common stock on January 15, 2026, in a transaction coded "A" for acquisition at a stated price of $0 per share. Following this transaction, she now beneficially owns 11,948 shares of the company’s common stock, held directly.
Alexandria Real Estate Equities, Inc. reported that Regional Market Director Stevens Blake L. beneficially owns 19,219 shares of the company’s common stock. This Form 3 filing, dated January 9, 2026, reflects his direct ownership position as an officer of the company and serves as his initial insider ownership disclosure under SEC rules.
Alexandria Real Estate Equities, Inc. director Richard Hunter Klein reported receiving 3,558 shares of common stock on January 15, 2026, at a price of $0 per share, indicating a grant or award rather than an open-market purchase. Following this transaction, he beneficially owns 21,643 shares of Alexandria common stock in direct form.